Endovenous Laser Ablation of the Great Saphenous Vein with a 1470 nm Wavelength Laser: Results of a Prospective, Single Centre Cohort Study

Background : Endovenous laser ablation (EVLA) is a widely accepted treatment for venous insufficiency. Our aim was to report the standardised technique used in our centre and to evaluate the anatomic and clinical success rates. Methods : All details of patients treated with EVLA were prospectively c...

Full description

Saved in:
Bibliographic Details
Published in:Acta chirurgica belgica 2014-07, Vol.114 (4), p.256-260
Main Authors: Steyaert, A., Letter, J. De, Lanckneus, M., Reusens, H.
Format: Article
Language:English
Subjects:
Catheter Ablation - methods
Endovascular Procedures - methods
Equipment Design
Female
Follow-Up Studies
Humans
Laser Therapy - instrumentation
Male
Prospective Studies
Saphenous Vein - diagnostic imaging
Saphenous Vein - surgery
Ultrasonography, Doppler, Duplex
Venous Insufficiency - diagnostic imaging
Venous Insufficiency - surgery
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background : Endovenous laser ablation (EVLA) is a widely accepted treatment for venous insufficiency. Our aim was to report the standardised technique used in our centre and to evaluate the anatomic and clinical success rates. Methods : All details of patients treated with EVLA were prospectively collected in a database. A standardized examination and surgical protocol was used, and every detail in the technique was registered. A follow-up visit was organised after 1 week and after 4-6 weeks with a duplex. Results : A total of 441 limbs were treated in 366 patients using a 1470 nm wavelength laser with bare tip fiber (Biolitec®). At 6 weeks postoperative a total obliteration of the vein was established in 98,62% of the cases with 78,67% of the patients free from complaints. No major complications were reported. Minor complaints were low (10,74% induration, 3,9% paresthesia). 93,11% reported no pain, 5,2% mentioned moderate pain. Mean duration of absence was equal or less than 1 week (65,28%). Satisfaction level was high (92,84%, level 10). Conclusion : EVLA of the GSV and the Anterior Accessory Vein (AAV) with a 1470 nm wavelength laser with bare tip fiber is a minimally invasive, safe and effective technique. We are convinced that every detail is important: tumescence technique, Trendelenburg position, no external compression, and the position of the vein in the fascial sheath. Further reduction of linear endovenous energy density (LEED) used for EVLA can improve the therapy. This is possible by using a new fiber tip design (radial optical fiber) and needs further investigation.
ISSN:0001-5458
DOI:10.1080/00015458.2014.11681022